SK81899A3 - Polypeptides of the "basic-helix-loop-helix" bhlh family, corresponding nucleic acid sequences - Google Patents

Polypeptides of the "basic-helix-loop-helix" bhlh family, corresponding nucleic acid sequences Download PDF

Info

Publication number: SK81899A3
Authority: SK; Slovakia
Prior art keywords: sequence; nucleic acid; seq; bhlh; helix
Prior art date: 1996-12-19

Application number

SK818-99A

Other languages

English (en)

Slovak (sk)

Inventor

Christine Icard-Liepkalns

Jacques Mallet

Philippe Ravassard

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-19

Filing date

1997-12-19

Publication date

2000-05-16

1997-12-19 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

2000-05-16 Publication of SK81899A3 publication Critical patent/SK81899A3/sk

Links

150000007523 nucleic acids Chemical group 0.000 title claims description 29
108090000765 processed proteins & peptides Proteins 0.000 title claims description 29
229920001184 polypeptide Polymers 0.000 title claims description 23
102000004196 processed proteins & peptides Human genes 0.000 title claims description 23
108090000623 proteins and genes Proteins 0.000 claims abstract description 45
102000004169 proteins and genes Human genes 0.000 claims abstract description 38
230000014509 gene expression Effects 0.000 claims description 25
239000013598 vector Substances 0.000 claims description 18
241000701161 unidentified adenovirus Species 0.000 claims description 16
239000002773 nucleotide Substances 0.000 claims description 13
125000003729 nucleotide group Chemical group 0.000 claims description 13
241000700605 Viruses Species 0.000 claims description 12
108091028043 Nucleic acid sequence Proteins 0.000 claims description 9
230000002103 transcriptional effect Effects 0.000 claims description 6
230000000295 complement effect Effects 0.000 claims description 5
239000008194 pharmaceutical composition Substances 0.000 claims description 5
241001430294 unidentified retrovirus Species 0.000 claims description 5
241000702421 Dependoparvovirus Species 0.000 claims description 3
210000000653 nervous system Anatomy 0.000 claims description 3
241000700618 Vaccinia virus Species 0.000 claims description 2
230000001575 pathological effect Effects 0.000 claims description 2
238000002360 preparation method Methods 0.000 claims description 2
239000013603 viral vector Substances 0.000 claims description 2
241001068295 Replication defective viruses Species 0.000 claims 1
108010027344 Basic Helix-Loop-Helix Transcription Factors Proteins 0.000 abstract description 13
102000018720 Basic Helix-Loop-Helix Transcription Factors Human genes 0.000 abstract description 13
239000013604 expression vector Substances 0.000 abstract description 6
230000001225 therapeutic effect Effects 0.000 abstract description 3
108020004635 Complementary DNA Proteins 0.000 description 38
238000010804 cDNA synthesis Methods 0.000 description 34
239000002299 complementary DNA Substances 0.000 description 34
108020004999 messenger RNA Proteins 0.000 description 21
102000039446 nucleic acids Human genes 0.000 description 18
108020004707 nucleic acids Proteins 0.000 description 18
210000004027 cell Anatomy 0.000 description 16
108091034117 Oligonucleotide Proteins 0.000 description 14
241000700159 Rattus Species 0.000 description 13
210000000278 spinal cord Anatomy 0.000 description 12
238000000034 method Methods 0.000 description 10
101000657037 Homo sapiens Radical S-adenosyl methionine domain-containing protein 2 Proteins 0.000 description 9
102100033749 Radical S-adenosyl methionine domain-containing protein 2 Human genes 0.000 description 9
230000002950 deficient Effects 0.000 description 9
239000012634 fragment Substances 0.000 description 9
239000013612 plasmid Substances 0.000 description 9
108091035710 E-box Proteins 0.000 description 8
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
125000003275 alpha amino acid group Chemical group 0.000 description 8
238000012217 deletion Methods 0.000 description 8
230000037430 deletion Effects 0.000 description 8
239000000835 fiber Substances 0.000 description 7
238000012986 modification Methods 0.000 description 7
230000004048 modification Effects 0.000 description 7
230000000694 effects Effects 0.000 description 6
150000001413 amino acids Chemical class 0.000 description 5
238000012512 characterization method Methods 0.000 description 5
230000013020 embryo development Effects 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
238000002955 isolation Methods 0.000 description 5
101150010353 Ascl1 gene Proteins 0.000 description 4
108020004414 DNA Proteins 0.000 description 4
102000040945 Transcription factor Human genes 0.000 description 4
108091023040 Transcription factor Proteins 0.000 description 4
230000002068 genetic effect Effects 0.000 description 4
238000009396 hybridization Methods 0.000 description 4
238000007901 in situ hybridization Methods 0.000 description 4
210000001161 mammalian embryo Anatomy 0.000 description 4
238000013518 transcription Methods 0.000 description 4
230000035897 transcription Effects 0.000 description 4
108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 3
241000701022 Cytomegalovirus Species 0.000 description 3
102100032063 Neurogenic differentiation factor 1 Human genes 0.000 description 3
108050000588 Neurogenic differentiation factor 1 Proteins 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
238000012408 PCR amplification Methods 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
230000000692 anti-sense effect Effects 0.000 description 3
238000009739 binding Methods 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
210000003169 central nervous system Anatomy 0.000 description 3
230000004069 differentiation Effects 0.000 description 3
210000002257 embryonic structure Anatomy 0.000 description 3
210000005036 nerve Anatomy 0.000 description 3
210000002569 neuron Anatomy 0.000 description 3
239000000523 sample Substances 0.000 description 3
238000006467 substitution reaction Methods 0.000 description 3
108091006106 transcriptional activators Proteins 0.000 description 3
230000002861 ventricular Effects 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
241000282465 Canis Species 0.000 description 2
108060001084 Luciferase Proteins 0.000 description 2
239000005089 Luciferase Substances 0.000 description 2
-1 Math-1 Proteins 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
108700008625 Reporter Genes Proteins 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
238000013459 approach Methods 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
238000012761 co-transfection Methods 0.000 description 2
238000004925 denaturation Methods 0.000 description 2
230000036425 denaturation Effects 0.000 description 2
238000009826 distribution Methods 0.000 description 2
230000006801 homologous recombination Effects 0.000 description 2
238000002744 homologous recombination Methods 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
230000035772 mutation Effects 0.000 description 2
230000004766 neurogenesis Effects 0.000 description 2
210000004129 prosencephalon Anatomy 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
238000012216 screening Methods 0.000 description 2
238000012163 sequencing technique Methods 0.000 description 2
238000001890 transfection Methods 0.000 description 2
208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 description 1
241000271566 Aves Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
241000701157 Canine mastadenovirus A Species 0.000 description 1
102100038909 Caveolin-2 Human genes 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
241000698776 Duma Species 0.000 description 1
108700011215 E-Box Elements Proteins 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
101000740981 Homo sapiens Caveolin-2 Proteins 0.000 description 1
241000598171 Human adenovirus sp. Species 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
241000701168 Murine adenovirus 1 Species 0.000 description 1
101000773193 Mus musculus Twist-related protein 1 Proteins 0.000 description 1
108091092724 Noncoding DNA Proteins 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
241001494479 Pecora Species 0.000 description 1
101100163890 Rattus norvegicus Ascl2 gene Proteins 0.000 description 1
101000606117 Rattus norvegicus Tyrosine 3-monooxygenase Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000003321 amplification Effects 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
238000000137 annealing Methods 0.000 description 1
239000000074 antisense oligonucleotide Substances 0.000 description 1
238000012230 antisense oligonucleotides Methods 0.000 description 1
108091067133 bHLH protein family Proteins 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000002146 bilateral effect Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
230000006870 function Effects 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
230000003037 histogenic effect Effects 0.000 description 1
210000003016 hypothalamus Anatomy 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000001823 molecular biology technique Methods 0.000 description 1
238000007857 nested PCR Methods 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
210000000276 neural tube Anatomy 0.000 description 1
230000007472 neurodevelopment Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
210000001428 peripheral nervous system Anatomy 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
108020001580 protein domains Proteins 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
238000003757 reverse transcription PCR Methods 0.000 description 1
210000001202 rhombencephalon Anatomy 0.000 description 1
239000000126 substance Substances 0.000 description 1
210000002222 superior cervical ganglion Anatomy 0.000 description 1
230000001629 suppression Effects 0.000 description 1
230000008685 targeting Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
230000003612 virological effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
Veterinary Medicine (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Animal Behavior & Ethology (AREA)
Physics & Mathematics (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Plant Pathology (AREA)
Public Health (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

SK818-99A 1996-12-19 1997-12-19 Polypeptides of the "basic-helix-loop-helix" bhlh family, corresponding nucleic acid sequences SK81899A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9615651A FR2757524B1 (fr)	1996-12-19	1996-12-19	Polypeptides de la famille bhlh, sequences d'acides nucleiques correspondantes
PCT/FR1997/002368 WO1998027206A2 (fr)	1996-12-19	1997-12-19	Polypeptides de la famille 'basic helix-loop-helix' bhlh, sequences d'acides nucleiques correspondantes

Publications (1)

Publication Number	Publication Date
SK81899A3 true SK81899A3 (en)	2000-05-16

Family

ID=9498862

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK818-99A SK81899A3 (en)	1996-12-19	1997-12-19	Polypeptides of the "basic-helix-loop-helix" bhlh family, corresponding nucleic acid sequences

Country Status (15)

Country	Link
US (1)	US6998474B1 (fr)
EP (1)	EP0946724A2 (fr)
JP (1)	JP2001510464A (fr)
KR (1)	KR20000057698A (fr)
AU (1)	AU732438B2 (fr)
BR (1)	BR9713968A (fr)
CA (1)	CA2275454A1 (fr)
CZ (1)	CZ219499A3 (fr)
FR (1)	FR2757524B1 (fr)
HU (1)	HU224305B1 (fr)
IL (1)	IL130302A0 (fr)
NO (1)	NO993029L (fr)
SK (1)	SK81899A3 (fr)
WO (1)	WO1998027206A2 (fr)
ZA (1)	ZA9711401B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPP495598A0 (en)	1998-07-30	1998-08-20	Walter And Eliza Hall Institute Of Medical Research, The	A novel regulatory molecule and genetic sequences encoding same
DE60034877T2 (de) *	1999-04-06	2008-01-17	The Regents Of The University Of California, Oakland	MENSCHLICHE, FüR NEUROGENIN 3 KODIERENDE NUKLEOTIDSEQUENZEN
EP1354951B1 (fr) *	2000-12-27	2008-06-04	Sumitomo Chemical Company, Limited	Methode d'examen de la capacite a controler la plasticite des cellules nerveuses
US20150315607A1 (en) *	2014-01-15	2015-11-05	Academia Sinica	Mutated nucleotide molecule, and transformed plant cells and plants comprising the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5695995A (en)	1994-05-06	1997-12-09	Fred Hutchinson Cancer Research Center	Neurogenic differentiation (neurod) genes
EP0759938A4 (fr) *	1994-05-06	1999-10-27	Hutchinson Fred Cancer Res	Proteines et genes de differentiation neurogene (neuro d)
US6566496B1 (en) *	1996-09-27	2003-05-20	California Institute Of Technology	Neurogenin

1996
- 1996-12-19 FR FR9615651A patent/FR2757524B1/fr not_active Expired - Fee Related
1997
- 1997-12-18 ZA ZA9711401A patent/ZA9711401B/xx unknown
- 1997-12-19 BR BR9713968-8A patent/BR9713968A/pt not_active IP Right Cessation
- 1997-12-19 HU HU0001184A patent/HU224305B1/hu not_active IP Right Cessation
- 1997-12-19 CZ CZ992194A patent/CZ219499A3/cs unknown
- 1997-12-19 JP JP52741598A patent/JP2001510464A/ja not_active Ceased
- 1997-12-19 EP EP97952961A patent/EP0946724A2/fr not_active Withdrawn
- 1997-12-19 IL IL13030297A patent/IL130302A0/xx unknown
- 1997-12-19 CA CA002275454A patent/CA2275454A1/fr not_active Abandoned
- 1997-12-19 AU AU56673/98A patent/AU732438B2/en not_active Ceased
- 1997-12-19 WO PCT/FR1997/002368 patent/WO1998027206A2/fr not_active Ceased
- 1997-12-19 SK SK818-99A patent/SK81899A3/sk unknown
- 1997-12-19 KR KR1019990705560A patent/KR20000057698A/ko not_active Ceased
1999
- 1999-06-18 NO NO993029A patent/NO993029L/no not_active Application Discontinuation
2000
- 2000-06-16 US US09/595,947 patent/US6998474B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL130302A0 (en)	2000-06-01
BR9713968A (pt)	2000-04-11
WO1998027206A2 (fr)	1998-06-25
JP2001510464A (ja)	2001-07-31
AU732438B2 (en)	2001-04-26
HUP0001184A3 (en)	2002-01-28
WO1998027206A3 (fr)	1998-10-01
FR2757524A1 (fr)	1998-06-26
HU224305B1 (hu)	2005-07-28
EP0946724A2 (fr)	1999-10-06
FR2757524B1 (fr)	1999-01-29
NO993029L (no)	1999-08-16
ZA9711401B (en)	1998-06-25
CA2275454A1 (fr)	1998-06-25
HUP0001184A2 (hu)	2000-08-28
AU5667398A (en)	1998-07-15
US6998474B1 (en)	2006-02-14
CZ219499A3 (cs)	1999-10-13
KR20000057698A (ko)	2000-09-25
NO993029D0 (no)	1999-06-18

Publication	Publication Date	Title
Porteus et al.	1991	Isolation and characterization of a novel cDNA clone encoding a homeodomain that is developmentally regulated in the ventral forebrain
Mansouri et al.	1997	Paired‐related murine homeobox gene expressed in the developing sclerotome, kidney, and nervous system
Jones et al.	1995	Nodal-related signals induce axial mesoderm and dorsalize mesoderm during gastrulation
Knöchel et al.	1992	Activin A induced expression of a fork head related gene in posterior chordamesoderm (notochord) of Xenopus laevis embryos
Quinn et al.	1997	Isolation and identification of homeobox genes from the human placenta including a novel member of the Distal-less family, DLX4
Vesque et al.	1996	Hoxb‐2 transcriptional activation in rhombomeres 3 and 5 requires an evolutionarily conserved cis‐acting element in addition to the Krox‐20 binding site.
Chowdhury et al.	1988	The primary structure of the murine multifinger gene mKr2 and its specific expression in developing and adult neurons.
JP2000513571A (ja)	2000-10-17	Ｄｐ．７５をコードするｄｎａおよびその使用のための工程
US5686598A (en)	1997-11-11	Genes associated with retinal dystrophies
Surguchov et al.	1997	The human GCAP1 and GCAP2 genes are arranged in a tail-to-tail array on the short arm of chromosome 6 (p21. 1)
Fujii et al.	1999	Sperizin is a murine RING zinc-finger protein specifically expressed in haploid germ cells
SK81899A3 (en)	2000-05-16	Polypeptides of the "basic-helix-loop-helix" bhlh family, corresponding nucleic acid sequences
WO1998055611A1 (fr)	1998-12-10	Element de reponse a la neureguline et ses utilisations
Takahara et al.	1995	Structural organization and genetic localization of the human bone morphogenetic protein 1/mammalian tolloid gene
Kenyon et al.	1999	Analysis of the 5′ regulatory region of the human Norrie’s disease gene: evidence that a non-translated CT dinucleotide repeat in exon one has a role in controlling expression
Busse et al.	1993	Isolation of cDNAs for two closely related members of the axolotl Wnt family, Awnt-5A and Awnt-5B, and analysis of their expression during development
WO2000066737A9 (fr)	2002-08-29	VARIANTES DE TRAF2 AGISSANT COMME INHIBITEURS DE LA VOIE DE SIGNALISATION TNF-ALPHA (TNF α)
JPH09508006A (ja)	1997-08-19	キネシンと化学療法薬に対する感受性との関連
Kondo et al.	1996	Molecular Cloning ofXenopusActivin Type I Receptor and the Analysis of Its Expression During Embryogenesis
US6998475B1 (en)	2006-02-14	Variants of traf2 which act as an inhibitor of tnf-alpha (tnfα) signaling pathway
JP4129227B2 (ja)	2008-08-06	神経芽細胞腫において単離された核酸
Yoshida et al.	1994	Retrotransposon-induced ectopic expression of the Om (2D) gene causes the eye-specific Om (M) phenotype in Drosophila ananassae
US6384204B1 (en)	2002-05-07	Reagents and methods for the screening of compounds useful in the treatment of neurological diseases
JP2003061672A (ja)	2003-03-04	新規ヒトｂｍｃｃ１遺伝子
Wu	1992	cDNA cloning, sequence analysis, and expression studies of the murine Hox-1.7 and Hox-1.8 homeobox genes and functional studies of the murine Hox-1.4 homeobox gene